| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V113285 | AE105 TFA | AE105 TFA is a probe composed of 9 peptides that targets the urokinase-type plasminogen activator receptor (uPAR). | |
|
V128399 | AGEN-1571 | AGEN-1571 is a human IgG1 monoclonal antibody (mAb) that targets ILT2. | |
|
V128417 | AGS-67E | AGS-67E is a humanized antibody expressed by CHO cells that targets TSPAN26/CD37. | |
|
V129567 | AT1412 | AT1412 is a CD9 binding antibody. | |
|
V130416 | BMS-986497 | BMS-986497 is an antibody-drug conjugate of GSPT1 that targets CD33. | |
|
V130420 | BND-35 | BND-35 is a human monoclonal antibody (mAb) that targets LILRB4/ILT3/CD85k. | |
|
V132039 | COM902 | COM902 is a human IgG4 monoclonal antibody (mAb) that targets TIGIT. | |
|
V133880 | DiOC14(3) hydroxyethanesulfonate | 3083251-08-2 | |
|
V135754 | Fanolesomab | Fanolesomab is a monoclonal antibody that targets human CD15. | |
|
V136857 | GPC3 targeting peptide 1 TFA | GPC3 targeting peptide 1 TFA is a GPC3 targeting peptide with a Kd value of 0.23 nM. | |
|
V137648 | Hyaluronan-binding peptide, biotin labeled TFA | Hyaluronan-binding peptide, biotin-labeled TFA, is a bioactive peptide. | |
|
V138514 | KRN-330 | KRN-330 is a humanized antibody expressed in CHO cells that targets GPA33. | |
|
V119810 | MEN1112 | MEN1112 (OBT357NF) is a selective humanized monoclonal antibody that targets Bst1/CD157 (EC50 = 1 nM). | |
|
V141352 | Nilvanstomig | 3061475-22-4 | Nilvanstomig is an antibody that targets PD-1 and TIGIT. |
|
V144260 | RO-5429083 | RO-5429083 is a humanized monoclonal antibody that targets CD44. | |
|
V144731 | SEA-TGT | SEA-TGT is a human monoclonal antibody (mAb) that targets TIGIT. | |
|
V144817 | SGC3 | ||
|
V145278 | ST2485 | ST2485 is a monoclonal anti-tendin antibody. | |
|
V145485 | SYL3C aptamer sodium scrambled negative control | The SYL3C aptamer sodium scrambled negative control is a negative control with the sequence of SYL3C aptamer sodium scrambled. | |
|
V145728 | Telimomab | Telimomab is an anti-human monoclonal antibody that targets CD5. |